The market is segmented based on
モノクローナル抗体の世界市場セグメンテーション、製造方法別（生体内、生体外）、供給源別（マウス、キメラ、ヒト化、ヒト、その他）、適応症別（がん、自己免疫疾患、炎症性疾患、感染症、その他）、投与経路別（静脈内、皮下、硝子体内、その他）、エンドユーザー別（病院、専門クリニック、在宅ケア、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他） – 2032年までの業界動向と予測
.
The Global Monoclonal Antibodies Market size was valued at USD 263.22 USD Billion in 2024.
The Global Monoclonal Antibodies Market is projected to grow at a CAGR of 13.4% during the forecast period of 2025 to 2032.
The major players operating in the market include Pfizer Inc. , GlaxoSmithKline plc , Novartis AG , Mylan N.V. , Teva Pharmaceutical Industries Ltd., Sanofi , F. Hoffmann-La Roche Ltd. , Zydus Cadila , Lupin , Amneal Pharmaceuticals LLC. , Regeneron Pharmaceuticals Inc. , Biogen , Eli Lilly and Company , AbbVie Inc. , Eisai Co.Ltd. ,Amgen Inc. , Bayer AG , Bristol-Myers Squibb Company , AstraZeneca , Johnson &, Johnson Private Limited .
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.